Patents-Review.com
🔗 Permalink
Assignee profile:

TIGENIX, S.A.U.

City:

Madrid

Country:

Spain

Published Applications:

15

Last publication date:

2022-10-06

Patent Grants:

8

Last grant date:

2025-01-07

Top Inventors for applications by TIGENIX, S.A.U.

These are the the leading inventors for applications assigned to TIGENIX, S.A.U.:

Recent patent applications by TIGENIX, S.A.U.

TIGENIX, S.A.U. based in Madrid, ES has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-10-06 ✅ Patent 12,186,344 granted on 2025-01-07
US20220313742A1
Human necessities

Cell populations having immunoregulatory activity, method for isolation and uses

 #2 | 2022-06-30
US20220202868A1
Human necessities

IMPROVED STEM CELL POPULATIONS FOR ALLOGENEIC THERAPY

 #3 | 2022-04-07
US20220104481A1
Human necessities

CRYOPRESERVATION OF STEM CELLS

 #4 | 2022-03-24
US20220088084A1
Human necessities

USES OF MESENCHYMAL STEM CELLS

 #5 | 2020-12-03
US20200376038A1
Human necessities

MESENCHYMAL STROMAL CELLS FOR TREATING SEPSIS

 #6 | 2020-04-02 ✅ Patent 11,253,632 granted on 2022-02-22
US20200101199A1
Human necessities

Biomaterial for suturing

 #7 | 2019-12-19 ✅ Patent 11,273,182 granted on 2022-03-15
US20190381106A1
Human necessities

Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease

 #8 | 2017-10-19 ✅ Patent 10,729,726 granted on 2020-08-04
US20170296585A1
Human necessities

Identification and isolation of multipotent cells from non-osteochondral mesenchymal tissue

 #9 | 2017-09-14 ✅ Patent 10,357,518 granted on 2019-07-23
US20170258851A1
Human necessities

Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease

 #10 | 2017-06-01
US20170151284A1
Human necessities

MESENCHYMAL STROMAL CELLS FOR TREATING SEPSIS

 #11 | 2017-05-18
US20170136065A1
Human necessities

MESENCHYMAL STROMAL CELLS FOR TREATING RHEUMATOID ARTHRITIS

 #12 | 2016-05-05
US20160120910A1
Human necessities

CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHODS FOR THE PREPARATION AND USES THEREOF

 #13 | 2015-03-05 ✅ Patent 10,758,575 granted on 2020-09-01
US20150065948A1
Human necessities

Use of adipose tissue-derived stromal stem cells in treating fistula

 #14 | 2014-03-13 ✅ Patent 10,548,924 granted on 2020-02-04
US20140072539A1
Human necessities

Use of adipose tissue-derived stromal stem cells in treating fistula

 #15 | 2010-04-22 ✅ Patent 8,999,709 granted on 2015-04-07
US20100098669A1
Human necessities

Use of adipose tissue-derived stromal stem cells in treating fistula

Also check out TIGENIX, S.A.U.'s (Madrid, Spain) applicant profile with 5 patent applications submitted.

AssigneeID:

58075 ⎘